Insulet, an innovative medical device company, has received FDA approval for its Omnipod Go system. Unlike Medtronic’s MimMed 780G pump, which also received FDA approval this week, the Omnipod Go system is for use by patients with Type 2 diabetes.

Do you want to be more emotionally intelligent at work? Consider using these 5 phrases:

1.       “I appreciate you/your work”
2.       “What can I do to help?”
3.       “I hear you/I’m listening”
4.       “What are your thoughts?”
5.       “I’d love to hear more about [X]. Can we set up some time to talk?”

According to research by Robert Half Talent Solutions, 46% of respondents are looking for a new job or plan to during the first six months of the year. Results like this show that the Great Resignation is a trend that will continue through 2023.

The Global Healthcare Contract Research Organization Market size was estimated at USD 50.92 billion in 2022, USD 56.86 billion in 2023, and is projected to grow at a CAGR of 11.80% to reach USD 124.30 billion by 2030.

As you may know, the mini-MD (Mini Medical School), providing a comprehensive, intensive, and sophisticated overview of the world of medicine, is designed for biopharma professionals who are not otherwise medically trained. Some doctors have also taken the program (CME credit is earned) and you can find their testimonials at https://bit.ly/3mVJlll.

The Muscular Dystrophy Association and Burn Boot Camp, a boutique fitness franchise, are teaming up again to raise awareness and money for those with Muscular Dystrophy. The seventh annual event is titled “Be Their Muscle” to remind people that working out is a privilege, not a chore.

In today's fast-paced and ever-changing business environment, effective interdepartmental communication and collaboration are more critical than ever before. When teams within an organization work together seamlessly, the result is improved efficiency, increased productivity, and a stronger competitive advantage.

Once again, Fierce Pharma is running its Fierce Madness tournament for the best drug advertisement of the year. Currently down to the sweet sixteen, click here to take a moment to check out the competition.

One of the most notable drugs that recently lost its US exclusivity was Abbvie’s Humira. Humira generated $18.62 billion in US sales in 2022. Others expected to join them this year are Johnson & Johnson’s Stelara, $6.39 billion US sales in 2022, Takeda’s Vyvanse, $2.53 billion US sales in 2022, Sanofi’s Aubagio, $1.5 billion US sales in 2022 and Roche’s Actemra, $1.2 billion US sales in 2022.

The Silicon Review has recognized The Bandish Group as one of the 50 most admired companies of the year. As a boutique life sciences executive search firm, The Bandish Group, has an excellent team with a proven and solid track record of influencing customer relations at all levels and matching talent with opportunities.

For the fifth straight year, Rocket Pharmaceuticals has partnered with organizations to light up landmarks and buildings globally to bring awareness to Rare Disease Day which is February 28, 2023, this year.

Congratulations to our leader, Jackie Bandish, for the much-deserved recognition as a Top 10 Inspiring Women Leader by IERA Women Leaders.

After a recent failed FDA lab test, Sun Pharma has issued a recall for its generic for high blood pressure. The pills were made in its Halol manufacturing plant in Gujarat, India. The pills were distributed nationwide within the US.

BioSpace has revealed the top life sciences organizations that have been selected as Best Places to Work in 2023.

Items most important to responders include workplace flexibility (namely remote work options), work-home balance awareness, cultures of inclusion and progressive diversity, and equity and inclusion (DEI) policies.

Expectations for an active M&A year were high going into 2022. The largest deals of the year totaled $65 billion which was a $12 billion increase over 2021 but significantly short of the $97 billion total in 2020. Showing that dealmakers seem to be taking a cautious approach to megadeals.

Wandercraft has produced a walking assist powered exoskeleton that has just received FDA approval in the US to treat stroke patients. The excoskeleton is a self-balancing, battery-powered device that can help intensive patients with gait training, especially for those with upper body limitations.

In an effort to improve the blood donation rates of people under the age of 30, Abbott has teamed with the Blood Centers of America to unveil a mixed-reality, VR-like experience for blood donation. The mixed reality setup allows participants to visit gardens full of trees and flowers while listening to soothing music during the blood donation experience.

After customer reports of product discoloration, Spectrum Laboratory Products has issued a voluntary recall of three lots of bulk compound epinephrine. The affected lots are 1KG0865, 2KL0353 and 2KF0151. Thus far, no adverse events related to the recall have been reported.

Thea Pharma, the U.S. subsidiary of France’s Laboratoires Théa, has received FDA approval for a preservative-free version of latanoprost formulations used to lower elevated intraocular pressure in the eyes.

Many companies currently sell latanoprost eye drops in the US but the existing options contain preservatives such as benzalkonium chloride that studies have shown to be potentially damaging to the eye surface.

Bill Anderson, Roche’s current pharma CEO and former Genentech CEO will be leaving Roche at the end of 2022. Anderson has been in his current role since 2019 and is leaving to “pursue other opportunities.”

Thomas Schinecker, who is slated to become Roche’s new CEO in March will take over as Pharma CEO until a replacement is found.